Download | < Back |
11 Oct 2021 | |
This is to inform the exchange that the Company has received Establishment Inspection Report (EIR) from US Food and Drug Administration (USFDA) for the inspection carried out by them at our New Injectable Facility (F-3) at Karakhadi during the period from 28th January, 2021 to 6th February, 2021, indicating that the USFDA finds our responses to their observations to be adequate. USFDA has also indicated that a compliance verification would be performed during re-inspection of the said Facility in the next review cycle. <BR> <BR> We request you to kindly take the same on record.<BR> | |
View all announcements for ALEMBIC PHARMACEUTICALS LTD. | Source: BSE India |